Rigaku Enters Strategic Alliance with Onto Innovation through 27 % Equity Investment
21.4.2026 01:14:00 CEST | Business Wire | Press Release
Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), a global leader in X-ray analytical technologies, today announced that it has entered into a strategic capital and business alliance with Onto Innovation Inc. (headquarters: Massachusetts, USA; CEO: Michael P. Plisinski; “Onto Innovation”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260420467739/en/
Double Logo
“As semiconductor devices become more complex, particularly with the increasing importance of three-dimensional structures, Rigaku has been seeking to enhance its analytical capabilities by incorporating advanced model-based and AI-driven algorithms in optical metrology,” said Jun Kawakami, President and CEO, Rigaku Holdings Corporation. “Onto Innovation not only brings strong expertise in optical technologies and software, but also capabilities in physical modeling for X-ray analysis, making it an ideal partner for us.”
This alliance directly supports Rigaku’s core growth strategy in semiconductor process control. By combining Rigaku’s X-ray technologies with Onto Innovation’s complementary optical metrology and advanced analytics software, including AI-driven solutions, the companies aim to deliver next-generation hybrid metrology solutions for increasingly complex semiconductor devices.
“The pace of change in semiconductor production is accelerating as the industry combines more complex and exotic materials with new 3D transistor structures, and advanced packaging to implement 3D and 2.5D chiplet architectures. ” said Michael P. Plisinski, CEO, Onto Innovation Inc. “These changes necessitate new and innovative ways to measure, characterize, and ultimately control theses new production technologies. We are pleased to be able to expand our partnership with Rigaku and together deliver the solutions our customers need to maintain their pace of innovation.”
The two companies have already been collaborating on hybrid metrology solutions, integrating Rigaku’s CD-SAXS with Onto Innovation’s analytics software. The new agreement will further accelerate and expand this joint development.
About Onto Innovation: Onto Innovation is a leader in process control, combining global scale with an expanded portfolio of leading-edge technologies that includes un-patterned wafer quality, 3D metrology spanning chip features from nanometer scale transistors to large die interconnects, macro defect inspection of wafers and packages, metal interconnect composition, factory analytics, and lithography for advanced semiconductor packaging. Headquartered in Wilmington, Massachusetts, Onto Innovation supports customers with a worldwide sales and service organization. For more information, visit https://ontoinnovation.com/
Strategic Highlights
- Aligned with core growth strategy: Strengthens Rigaku’s offering in semiconductor process control, a key driver of future growth
- Highly complementary technologies: Rigaku’s X-ray solutions and Onto Innovation’s complementary optical and software capabilities present strong synergies benefitting customers with deeper process insights
- Positioned for evolving industry structure: Responding to increasingly sophisticated customer requirements and growing complexity in semiconductor manufacturing
- Strengthening competitiveness: Transaction enables Rigaku to be even more competitive in semiconductor process control segment
Key Initiatives
- Establishing hybrid metrology for Front End Of Line: Enhancing measurement capabilities for advanced logic and memory devices through the combination of X-ray and optical technologies
- Expansion into advanced packaging: Accelerating entry into inspection and metrology applications in advanced packaging
- New market creation: Targeting at least $300 million in incremental market opportunity for Rigaku’s products by 2030
- Integration of software and AI: Supporting the development of integrated solutions spanning measurement, analysis, process optimization, and yield management
- Global customer reach: Utilizing Onto Innovation’s global customer base to expand Rigaku’s market presence
Equity Investment
Onto Innovation has entered into a definitive agreement to acquire 61,123,436 shares (27.0% of total shares outstanding as of March 31, 2026, excluding treasury shares) of Rigaku from Atom Investment, L.P., establishing a long-term strategic alliance between the two companies.
Governance
Rigaku will maintain its management independence as a publicly listed company. The agreement also includes provisions to ensure a stable, long-term alliance, including certain restrictions on share transfers and additional acquisitions.
For more details, please refer to the timely disclosure released today, available on Rigaku’s website and the Tokyo Stock Exchange website.
About the Rigaku Group
Since its establishment in 1951, the engineering professionals of the Rigaku group have been dedicated to benefiting society with leading-edge technologies, notably including its core fields of X-ray and thermal analysis. With a market presence in 136 countries and regions and some 2,000 employees from 9 global operations, Rigaku is a solution partner in industry and research analysis institutes. Our overseas sales ratio has reached approximately 70% while sustaining an exceptionally high market share in Japan. Together with our customers, we continue to develop and grow. As applications expand from semiconductors, electronic materials, batteries, environment, resources, energy, life science to other high-tech fields, Rigaku realizes innovations “To Improve Our World by Powering New Perspectives.”
For details, please visit: rigaku-holdings.com/english
View source version on businesswire.com: https://www.businesswire.com/news/home/20260420467739/en/
Contacts
Press Contact:
Sawa Himeno
Director, Communications Dept., Rigaku Holdings Corporation
prad@rigaku.co.jp
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SES Announces Extraordinary General Meeting of Shareholders15.5.2026 08:30:00 CEST | Press Release
SES: Société Anonyme RCS Luxembourg B 81267 Notice is hereby given of the Extraordinary General Meeting of SES, Société Anonyme, to be held at the Company's registered office at Château de Betzdorf, L-6815 Betzdorf (the "Company"), Luxembourg, on Wednesday 17 June 2026 at 3:00 p.m. CET AGENDA Attendance list, quorum and adoption of the agenda Nomination of a secretary and of two scrutineers Cancellation of shares purchased in connection with the buy-back programme of 2 November 2023, as amended on 2 May 2024, in accordance therewith and pursuant thereto - Reduction of the share capital in accordance with article 450-5 of the law of 10 August 1915 on commercial companies, as amended, by forty-four million nine hundred ten thousand seven hundred eighty euro (EUR 44,910,780) through the cancellation of thirty-five million nine hundred and twenty-eight thousand six hundred and twenty-four (35,928,624) shares divided into (i) twenty-three million nine hundred and fifty-two thousand four hun
Cinemo Honored with 2026 AutoX Award for Automotive Infotainment Innovation15.5.2026 08:05:00 CEST | Press Release
Cinemo, global leader in AI-powered, fully integrated in-vehicle entertainment and digital media solutions, delivering seamless multi-screen experiences for drivers and passengers, has been recognized as an Automotive Infotainment Innovator at the 2026 AutoX Innovator Awards by Compass Intelligence, highlighting its role in shaping the next generation of in-vehicle experiences. The AutoX Innovator Awards recognize companies that move the industry forward. Winners are selected based on criteria including technological advancement, differentiation, integration capabilities, user experience, industry partnerships, and feasibility. Additional emphasis is placed on real-world outcomes, such as improving driver safety, enhancing passenger experiences, delivering positive market impact, and transforming mobility. “Cinemo exemplifies the future of automotive infotainment, where innovation is defined not just by technology, but by the experiences it enables,” said Stephanie Atkinson, CEO of Com
Experian Partners With ServiceNow to Scale Trusted Decisioning to Agentic AI15.5.2026 08:00:00 CEST | Press Release
Experian, the global data and technology company, and ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today unveil a new global multi-year partnership which harnesses the power of autonomous AI agents across platforms, helping businesses make faster and smarter decisions at scale. Through this partnership, autonomous AI agents can gain the ability to act faster, and more consistently, starting with employee onboarding, third-party risk management and model life cycle governance use cases. A major challenge for global organisations adopting agentic AI is achieving scale, with deployments often constrained by a lack of trusted data. In fact, industry research shows that data limitations are the primary barrier for eight in ten organisations. By connecting trusted intelligence directly into enterprise workflows, this partnership enables agentic AI to scale well beyond pilot deployments. With the Experian Ascend Platform natively connected to the ServiceNow AI Platfo
Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet15.5.2026 03:00:00 CEST | Press Release
Meiji Seika Pharma Co., Ltd. (headquartered in Tokyo; President and Representative Director: Toshiaki Nagasato) today announced that the results of the Integral-1 study, one of two global Phase III clinical trials evaluating the efficacy and safety of its novel β-lactamase inhibitor nacubactam (development code: OP0595), have been published in The Lancet. The article is entitled “---Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with imipenem–cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial” (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00596-9/fulltext) Integral-1 is a global, double-blind, randomized Phase III trial (jRCT2031230075) in patients with complicated urinary tract infection or acute uncomplicated pyelonephritis that compared the efficacy and safety of nacubactam co-administered with either cefepime or aztreonam versus imipenem-c
Boomi Teams up With Gong to Bring Revenue AI to Boomi Agentstudio14.5.2026 18:00:00 CEST | Press Release
Boomi, the data activation company for AI, today announced a collaboration withGong, the leader in Revenue AI, to bring revenue signals captured in Gong natively into the Boomi Enterprise Platform. This collaboration enables enterprises to establish an active data foundation designed to transform customer conversations into coordinated, automated actions across systems and functions enterprise-wide with Boomi Agentstudio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514443012/en/ Boomi Teams Up with Gong to Bring Revenue AI to Boomi Agentstudio Gong goes beyond capturing deal activity to surface real-time insights into risk, buyer intent, competitive dynamics, and key engagement signals. That intelligence moves from conversation to coordinated action, flowing across CRM, ERP, product, and operational systems with the governance and security that enterprises require. Through this collaboration, these signals can be serve
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom